Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe Locations section now includes Texas as a site and removes the prior separate 'Texas Locations' listing; the footer no longer shows the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe Publications section now notes that PubMed publications are automatically filled and may not relate to the study, and the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe funding status notice was removed from the page, and the study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedNo meaningful changes detected between the two screenshots of the Study Details page for NCT01585194.SummaryDifference0.4%

- Check80 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference4%

- Check87 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0 with substantial addition of immunology-related terms and related categories.SummaryDifference1%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.